Archive · 26 Jul 2025
NephroPlus Files ₹353 Crore IPO with SEBI
NephroPlus, a company that helps people with kidney problems, is planning to raise money by selling shares through an IPO.
They have asked SEBI, the financial regulator, for permission to do this and hope to get ₹353 crore.
They will use the money to build new clinics and pay back loans.
NephroPlus already has many clinics in India and helps a lot of patients with dialysis.
Last year, they made a lot of money.
NephroPlus filed a draft prospectus with SEBI for a ₹353 crore IPO.
The IPO includes a fresh issue of equity shares and an offer for sale by existing shareholders.
Funds will be used for capital expenditure and debt repayment.
NephroPlus is the largest dialysis service network in India, operating 447 clinics.
The company reported ₹755 crore revenue and ₹67 crore net profit in FY25.
- Who
- NephroPlus, a dialysis service provider.
- What
- NephroPlus filed for an IPO to raise funds.
- When
- The DRHP was filed on July 26, 2025.
- Where
- With SEBI in India.
- Why
- To raise funds for expansion and debt repayment.
- Company
- NephroPlus
- IPO Amount
- ₹353 crore
- Use of Funds
- Capital expenditure, debt repayment
- Clinics
- 447
- FY25 Revenue
- ₹755 crore
- FY25 Net Profit
- ₹67 crore